On BrandweekNRX is a fascinating post on the disdain European pharmaceutical executives have for direct to patient (DCT) pharma advertising. On UK executive even said "that American drug advertising was regarded as so excessive in the UK that it had actually nixed the chances of UK drug companies being allowed to conduct similar promotions."
And the post started with a link to Question Authority with Dr Peter Rost which cited a commentary in a left-wing Swedish newspaper in which a Swedish Pfizer executive called DTC advertising "a bad model for Sweden."
So why do American pharma executives swear by DTC advertising? Are they dumber than their European counterparts, or are American consumers more gullible than European consumers?
"She initially was berated and belittled by university officials, including the president, Mark Yudof, and his staff and sycophants, who portrayed her (and her legal counsel, the late Jim Lord) as a lone wolf in the cheating scheme, and a traitorous ingrate for subsequently blowing the whistle and disclosing it." - Marshall Tanick remembers Jan Gangelhoff and and the U's notorious athletic cheating scandal.
1 hour ago